Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scientists at Innate Pharma divulge new MAbs for cancer

Aug. 29, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Novel lung cancer vaccine CV-9202 evaluated in phase I trial

Aug. 23, 2013

Generation of a human anticancer immune response using a dendritic cell-based vaccine

Aug. 22, 2013

MacroGenics doses first patient in phase I MGA-271 trial

Aug. 21, 2013

Patient enrolled in brain tumor vaccine trial at Northwestern Memorial Hospital

Aug. 19, 2013

Amorfix Life Sciences provides update on ovarian cancer program

Aug. 19, 2013

ADXS-HPV receives orphan drug designation for HPV-associated anal cancer

Aug. 19, 2013

Phase II trial of Adcetris in combination with standard of care for frontline DLBCL commences

Aug. 19, 2013

Altor receives IND clearance to advance ALT-803 into clinical trials in melanoma

Aug. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...